首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1609868

日本免疫组织化学市场报告（按产品（抗体、设备、试剂、试剂盒）、应用（诊断、药物测试）、最终用户（医院和诊断实验室、研究机构等）和地区 2025-2033

Japan Immunohistochemistry Market Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Drug Testing), End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Region 2025-2033

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 117 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2024年日本免疫组化市场规模达1.777IMARC Group美元。与年龄相关的疾病的日益流行、强大的医疗基础设施的存在、对个人化医疗的认识不断增强、政府对医学研究的资金和支持不断增加，以及病理学领域的最新进展是推动市场的一些关键因素。

免疫组织化学 (IHC) 是一种诊断和研究技术，利用抗原抗体相互作用的原理来识别组织样本中的特定蛋白质、抗原或细胞。它涉及将抗体应用到装有组织切片的玻片上，然后与感兴趣的抗原反应，并使用显色或萤光染料进行可视化。免疫组织化学有多种类型，包括显色、萤光和多重。它由几个组件组成，例如一抗、二抗、检测系统和底物。 IHC 提供多种功能，包括高特异性、灵敏度以及准确定位细胞成分的能力。它广泛应用于肿瘤学、神经生物学、传染病和组织形态发生。免疫组织化学也应用于法医学、环境研究和药物测试。它具有成本效益、速度和处理大样本量的能力。除此之外，免疫组织化学以其微创性、提供原位分析的能力、定量能力以及与高通量筛选自动化技术的无缝整合而闻名。

日本免疫组织化学市场趋势：

由于日本阿兹海默症和癌症等与年龄相关的疾病日益流行，对免疫组织化学的需求不断增长，推动了市场的成长。此外，强大的医疗保健基础设施支援采用 IHC 等复杂的诊断技术，正在推动市场成长。此外，人们对个人化医疗的认识不断增强，这增加了对标靶诊断技术的需求，从而促进了市场的成长。此外，政府对医学研究的资金和支持不断增加也促进了市场的成长。除此之外，生活方式疾病的发生率不断上升，需要早期和精确的诊断，这对市场成长产生了积极影响。此外，病理学领域的最新进展使 IHC 变得更加重要，特别是对于基于组织的诊断，从而推动了市场的成长。同时，学术界和工业界之间不断加强的合作促进了 IHC 的研发 (R&D)，正在推动市场成长。与此一致的是，日本 IHC 流程的自动化程度不断提高，减少了人工错误并提高了通量，正在加速市场成长。此外，IHC 在药物开发和测试中的广泛应用开闢了新的扩张途径，也是另一个成长诱导因素。除此之外，影像技术的快速进步增强了 IHC 的能力，也刺激了市场的成长。此外，日本不断增长的医疗保健支出允许整合先进的诊断技术，这也推动了全国市场的成长。

日本免疫组织化学市场细分：

产品见解：

抗体
一抗
二抗
装置
玻片染色系统
组织微阵列
组织处理系统
玻片扫描仪
其他的
试剂
组织学染色
封闭血清和试剂
显色底物
固定试剂
稳定剂
有机溶剂
蛋白水解酶
稀释剂
套件

应用见解：

诊断
癌症
传染病
心血管疾病
自体免疫疾病
糖尿病
肾臟病
药物检测

最终使用者见解：

医院和诊断实验室
研究所
其他的

竞争格局：

市场研究报告也对竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

到目前为止，日本免疫组织化学市场的表现如何，未来几年又会如何表现？
COVID-19 对日本免疫组织化学市场有何影响？
日本免疫组化市场的产品细分如何？
日本免疫组化市场在应用上的细分如何？
日本免疫组织化学市场的最终用户细分如何？
日本免疫组织化学市场价值链的各个阶段是什么？
日本免疫组化的关键驱动因素和挑战是什么？
日本免疫组化市场的结构如何？
日本免疫组化市场的竞争程度如何？

本报告回答的关键问题：

到目前为止，日本免疫组织化学市场的表现如何，未来几年又会如何表现？
COVID-19 对日本免疫组织化学市场有何影响？
日本免疫组化市场的产品细分如何？
日本免疫组化市场在应用上的细分如何？
日本免疫组织化学市场的最终用户细分如何？
日本免疫组织化学市场价值链的各个阶段是什么？
日本免疫组化的关键驱动因素和挑战是什么？
日本免疫组化市场的结构如何？
日本免疫组化市场的竞争程度如何？

抗体
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场区隔
  - 一抗
  - 二抗
- 市场预测（2025-2033）
装置
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场区隔
  - 玻片染色系统
  - 组织微阵列
  - 组织处理系统
  - 玻片扫描仪
  - 其他的
- 市场预测（2025-2033）
试剂
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场区隔
  - 组织学染色
  - 封闭血清和试剂
  - 显色底物
  - 固定试剂
  - 稳定剂
  - 有机溶剂
  - 蛋白水解酶
  - 稀释剂
- 市场预测（2025-2033）
套件
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 7 章：日本免疫组织化学市场 - 细分：按应用分类

诊断
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场区隔
  - 癌症
  - 传染病
  - 心血管疾病
  - 自体免疫疾病
  - 糖尿病
  - 肾臟病
- 市场预测（2025-2033）
药物检测
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 8 章：日本免疫组织化学市场 - 细分：按最终用户划分

医院和诊断实验室
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
研究所
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
其他的
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 9 章：日本免疫组织化学市场 - 竞争格局

概述
市场结构
市场参与者定位
最佳制胜策略
竞争仪表板
公司评估象限

第 10 章：关键参与者简介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 11 章：日本免疫组织化学市场 - 产业分析

驱动因素、限制因素和机会
- 概述
- 司机
- 限制
- 机会
波特五力分析
- 概述
- 买家的议价能力
- 供应商的议价能力
- 竞争程度
- 新进入者的威胁
- 替代品的威胁
价值链分析

第 12 章：附录

简介目录

Product Code: SR112024A18972

Japan immunohistochemistry market size reached USD 177.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 321.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.1% during 2025-2033. The increasing prevalence of age-related diseases, presence of a strong healthcare infrastructure, growing awareness about personalized medicine, escalating funding and support by the government for medical research, and recent advancements in the field of pathology represent some of the key factors driving the market.

Immunohistochemistry (IHC) refers to a diagnostic and research technique that utilizes the principle of antigen-antibody interactions to identify specific proteins, antigens, or cells within tissue samples. It involves applying antibodies to a slide holding tissue sections, which then react with the antigen of interest and are visualized using chromogenic or fluorescent dyes. Immunohistochemistry is available in several types, including chromogenic, fluorescent, and multiplex. It is comprised of several components, such as primary antibodies, secondary antibodies, detection systems, and substrates. IHC offers multiple features, including high specificity, sensitivity, and the ability to localize cellular components accurately. It is widely used in oncology, neurobiology, infectious diseases, and tissue morphogenesis. Immunohistochemistry also finds application in forensics, environmental studies, and drug testing. It offers cost-effectiveness, speed, and the capability to handle large sample volumes. In addition to this, immunohistochemistry is known for its minimal invasiveness, ability to provide in situ analysis, quantitative capabilities, and seamless integration with automation technology for high-throughput screenings.

Japan Immunohistochemistry Market Trends:

The growing demand for immunohistochemistry, owing to the increasing prevalence of age-related diseases like Alzheimer's and cancer in Japan, is propelling the market growth. Additionally, the presence of a strong healthcare infrastructure, which supports the adoption of complex diagnostic technologies like IHC, is driving the market growth. Furthermore, the growing awareness about personalized medicine, which is enhancing the demand for targeted diagnostic techniques, is contributing to the market growth. In addition, the escalating funding and support by the government for medical research are catalyzing the market growth. Apart from this, the rising incidences of lifestyle diseases, necessitating early and precise diagnosis, are positively influencing the market growth. Moreover, recent advancements in the field of pathology that are making IHC more crucial, especially for tissue-based diagnoses, are fueling the market growth. Along with this, the rising cooperation between academia and industry, facilitating research and development (R&D) in IHC, is driving the market growth. In line with this, the increasing automation in IHC processes in Japan, which reduces manual errors and enhances throughput, is accelerating the market growth. Furthermore, the broadening application of IHC in drug development and testing, which is opening new avenues for expansion, is acting as another growth-inducing factor. Besides this, rapid improvements in imaging technologies that are enhancing the capabilities of IHC are stimulating the market growth. Additionally, the escalating healthcare expenditure in Japan, which allows for the integration of advanced diagnostic technologies, is providing a boost to the market growth across the country.

Japan Immunohistochemistry Market Segmentation:

Product Insights:

Antibodies
Primary Antibodies
Secondary Antibodies
Equipment
Slide Staining Systems
Tissue Microarrays
Tissue Processing Systems
Slide Scanners
Others
Reagents
Histological Stains
Blocking sera and Reagents
Chromogenic Substrates
Fixation Reagents
Stabilizers
Organic Solvents
Proteolytic Enzymes
Diluents
Kits

Application Insights:

Diagnostics
Cancer
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Diabetes Mellitus
Nephrological Diseases
Drug Testing

End User Insights:

Hospitals and Diagnostic Laboratories
Research Institutes
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan immunohistochemistry market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan immunohistochemistry market?
What is the breakup of the Japan immunohistochemistry market on the basis of product?
What is the breakup of the Japan immunohistochemistry market on the basis of application?
What is the breakup of the Japan immunohistochemistry market on the basis of end user?
What are the various stages in the value chain of the Japan immunohistochemistry market?
What are the key driving factors and challenges in the Japan immunohistochemistry?
What is the structure of the Japan immunohistochemistry market and who are the key players?
What is the degree of competition in the Japan immunohistochemistry market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Immunohistochemistry Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Immunohistochemistry Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Immunohistochemistry Market - Breakup by Product

6.1 Antibodies
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Primary Antibodies
  - 6.1.3.2 Secondary Antibodies
- 6.1.4 Market Forecast (2025-2033)
6.2 Equipment
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Slide Staining Systems
  - 6.2.3.2 Tissue Microarrays
  - 6.2.3.3 Tissue Processing Systems
  - 6.2.3.4 Slide Scanners
  - 6.2.3.5 Others
- 6.2.4 Market Forecast (2025-2033)
6.3 Reagents
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Segmentation
  - 6.3.3.1 Histological Stains
  - 6.3.3.2 Blocking sera and Reagents
  - 6.3.3.3 Chromogenic Substrates
  - 6.3.3.4 Fixation Reagents
  - 6.3.3.5 Stabilizers
  - 6.3.3.6 Organic Solvents
  - 6.3.3.7 Proteolytic Enzymes
  - 6.3.3.8 Diluents
- 6.3.4 Market Forecast (2025-2033)
6.4 Kits
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)

7 Japan Immunohistochemistry Market - Breakup by Application

7.1 Diagnostics
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Segmentation
  - 7.1.3.1 Cancer
  - 7.1.3.2 Infectious Diseases
  - 7.1.3.3 Cardiovascular Diseases
  - 7.1.3.4 Autoimmune Diseases
  - 7.1.3.5 Diabetes Mellitus
  - 7.1.3.6 Nephrological Diseases
- 7.1.4 Market Forecast (2025-2033)
7.2 Drug Testing
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)

8 Japan Immunohistochemistry Market - Breakup by End User

8.1 Hospitals and Diagnostic Laboratories
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Research Institutes
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Others
- 8.3.1 Historical and Current Market Trends (2019-2024)
- 8.3.2 Market Forecast (2025-2033)

9 Japan Immunohistochemistry Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Immunohistochemistry Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis